EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration

Mandy Hector, Verena Behnke, Paulina Dabrowska-Schlepp, Andreas Busch, Andreas Schaaf, Thomas Langmann, Anne Wolf

Journal of Neuroinflammation · 11.04.2025 · 22 (1)

DOI: 10.1186/s12974-025-03418-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroinflammation, online erschienen am 11.04.2025. Verfasst von Mandy Hector und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Co…. Hauptthemen laut MEDLINE: Complement Factor H, Retina, Retinal Degeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eleva GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: AMD is a multifactorial progressive disease of the central retina that leads to severe vision loss among the elderly. Genome-wide association studies in AMD patients and preclinical data have identified a dysregulated complement system and aberrant microglia responses in the pathogenesis of AMD. Specifically, a genetic variant in the complement factor H (CFH) gene, an important inhibitor of the alternative complement pathway, confers the strongest risk for AMD. Here, we investigated whether moss-derived recombinant human CFH proteins, termed CPV-101 and CPV-104, can modulate microglia reactivity and limit retinal degeneration in a murine light damage paradigm mimicking important features of AMD. METHODS: Two glycosylated human recombinant CFH proteins CPV101, and CPV-104 were produced in moss suspension cultures. In addition, glycans of the CPV-104 variant are sialylated, an optimization that makes CPV-104 an analog of human CFH. BALB/cJ mice received intravitreal injections of 5 µg CPV-101 and CPV-104 or vehicle, starting 1 day prior to exposure to 10,000 lx white light for 30 min. The effects of CPV-101 and CPV-104 treatment on mononuclear phagocyte and Müller cell reactivity were analyzed by immunostainings of retinal sections and flat mounts. Gene expression of microglia markers was analyzed using quantitative real-time PCR (qRT-PCR). Optical coherence tomography (OCT); Blue Peak Autofluorescence (BAF); terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and morphometric analyses were used to quantify the extent of retinal degeneration and photoreceptor apoptosis. RESULTS: Light-exposed mice treated with moss-derived recombinant human full-length CFH showed reduced complement activation and MAC deposition in the retina. Concomitantly, mononuclear phagocyte and Müller cell reactivity in light-exposed retinas were also ameliorated upon CFH substitution. Moreover, attenuated light-induced retinal degeneration was detected in mice that received moss-derived CFH. CONCLUSION: Modulating the alternative complement pathway using moss-derived recombinant human full-length CFH variant CPV-101 and CPV-104 counter-regulate gliosis and attenuates light-induced retinal degeneration, highlighting a promising concept for the treatment of AMD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement Factor HRetinaRetinal DegenerationAnimalsHumansMiceMice, Inbred BALB CBryopsidaRecombinant ProteinsDisease Models, AnimalMaleCells, Cultured

Stichwörter der Autor:innen

CPV-101CPV-104Complement factor HLight damageMicrogliaMoss-derived recombinant CFHRetinal degeneration

Substanzen

Complement Factor HRecombinant ProteinsCFH protein, human

Autor:innen und Institutionen

  • Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931, Cologne, Germany.
  • Eleva GmbH, Hans-Bunte-Straße 19, 79108, Freiburg, Germany.
  • Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
  • Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931, Cologne, Germany. anne.wolf@uk-koeln.de.
  • Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany. anne.wolf@uk-koeln.de.

Förderung

  • Eleva GmbH

Zitieren

APA

Hector, M., Behnke, V., Dabrowska-Schlepp, P., Busch, A., Schaaf, A., Langmann, T., & Wolf, A. (2025). Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration. Journal of Neuroinflammation, 22(1). https://doi.org/10.1186/s12974-025-03418-2

Vancouver

Hector M, Behnke V, Dabrowska-Schlepp P, Busch A, Schaaf A, Langmann T, et al. Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration. Journal of Neuroinflammation. 2025;22(1). doi:10.1186/s12974-025-03418-2

BibTeX
@article{Hector2025,
  author = {Hector, Mandy and Behnke, Verena and Dabrowska-Schlepp, Paulina and Busch, Andreas and Schaaf, Andreas and Langmann, Thomas and Wolf, Anne},
  title = {Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration},
  journal = {Journal of Neuroinflammation},
  year = {2025},
  volume = {22},
  number = {1},
  doi = {10.1186/s12974-025-03418-2}
}
Kostenlos starten →